
Inogen fell 12.5% from $6.99 to $6.12, behind the S&P 500's +9.8%. Its worst day was Jan 12 (−11.7%), and its low came Sep 23 at $5.09.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Inogen (NASDAQ:INGN) lowers FY2025 sales outlook from $354.000 million-$357.000 million to $349.000 million vs $355.600 million estimate.
−11.7%, the year's worst day · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
EPS of $-0.15 beat the $-0.25 estimate on $81.7M revenue (est. $82.0M); Q1 revenue guidance of $82.3M against the $82.0M consensus.
+2.9% · S&P 500 +0.8%
Inogen closed at its highest level of the year, 5.2% above where the year started.
+1.4% · S&P 500 −0.5%
EPS of $-0.14 beat the $-0.22 estimate on $85.1M revenue (est. $82.4M); FY revenue guidance of $366.0M–$373.0M against the $369.2M consensus.
−2.4% · S&P 500 +0.8%
EPS of $0.00 beat the $-0.08 estimate on $95.1M revenue (est. $95.1M); Q3 revenue guidance of $92.4M against the $98.6M consensus.
−6.8% · S&P 500 +0.6%
Inogen closed at its lowest level of the year, 27.2% below where the year started.
−2.7% · S&P 500 −0.7%
Inogen shares rose 13.5%, while the S&P 500 rose 0.2%.
+13.5%, the year's best day, on 1M shares, the year's heaviest volume · S&P 500 +0.2%
EPS of $-0.02 beat the $-0.07 estimate on $77.2M revenue (est. $92.3M); Q4 revenue guidance of $65.0M–$68.0M against the $84.0M consensus.
−10.9% · S&P 500 +0.3%
Where it ended: a close of $6.12 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $-0.13, revenue est. $66.0M).
Nothing in the past 12 months.
All INGN dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INGN and SPY from Benzinga historical bars. Not investment advice.